
Laura K. Tso
Examiner (ID: 1977, Phone: (571)272-2385 , Office: P/2875 )
| Most Active Art Unit | 2875 |
| Art Unit(s) | 2875, 3303, 3302, 2109, 2831, 2103 |
| Total Applications | 3051 |
| Issued Applications | 2669 |
| Pending Applications | 113 |
| Abandoned Applications | 284 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6682811
[patent_doc_number] => 20030118675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Recovery of isoflavones from soy molasses'
[patent_app_type] => new
[patent_app_number] => 10/318154
[patent_app_country] => US
[patent_app_date] => 2002-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8688
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20030118675.pdf
[firstpage_image] =>[orig_patent_app_number] => 10318154
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/318154 | Recovery of isoflavones from soy molasses | Dec 11, 2002 | Issued |
Array
(
[id] => 6639457
[patent_doc_number] => 20030212037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Use of bvdu for inhibiting the growth of hyperproliferative cells'
[patent_app_type] => new
[patent_app_number] => 10/168722
[patent_app_country] => US
[patent_app_date] => 2002-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8022
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20030212037.pdf
[firstpage_image] =>[orig_patent_app_number] => 10168722
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/168722 | Use of bvdu for inhibiting the growth of hyperproliferative cells | Dec 9, 2002 | Abandoned |
Array
(
[id] => 6740776
[patent_doc_number] => 20030158145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Crystalline drug form'
[patent_app_type] => new
[patent_app_number] => 10/308805
[patent_app_country] => US
[patent_app_date] => 2002-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8055
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20030158145.pdf
[firstpage_image] =>[orig_patent_app_number] => 10308805
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/308805 | Crystalline drug form | Dec 2, 2002 | Issued |
Array
(
[id] => 6639182
[patent_doc_number] => 20030212013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-13
[patent_title] => 'Use of amp kinase activators for treatment type 2 diabetes and insulin resistance'
[patent_app_type] => new
[patent_app_number] => 10/297114
[patent_app_country] => US
[patent_app_date] => 2002-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8468
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20030212013.pdf
[firstpage_image] =>[orig_patent_app_number] => 10297114
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/297114 | Use of amp kinase activators for treatment type 2 diabetes and insulin resistance | Dec 2, 2002 | Abandoned |
Array
(
[id] => 985543
[patent_doc_number] => 06924271
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-08-02
[patent_title] => '3-β-D-ribofuranosylthiazolo[4-5-d]pyridimine nucleosides and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/305061
[patent_app_country] => US
[patent_app_date] => 2002-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15573
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/924/06924271.pdf
[firstpage_image] =>[orig_patent_app_number] => 10305061
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/305061 | 3-β-D-ribofuranosylthiazolo[4-5-d]pyridimine nucleosides and uses thereof | Nov 26, 2002 | Issued |
Array
(
[id] => 1053295
[patent_doc_number] => 06858624
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-02-22
[patent_title] => 'Aryl fused azapolycyclic compounds'
[patent_app_type] => utility
[patent_app_number] => 10/306500
[patent_app_country] => US
[patent_app_date] => 2002-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3709
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/858/06858624.pdf
[firstpage_image] =>[orig_patent_app_number] => 10306500
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/306500 | Aryl fused azapolycyclic compounds | Nov 26, 2002 | Issued |
Array
(
[id] => 1271543
[patent_doc_number] => 06653425
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-25
[patent_title] => 'High refractive index and high photosensitive optical materials and method for preparing the same'
[patent_app_type] => B1
[patent_app_number] => 10/306280
[patent_app_country] => US
[patent_app_date] => 2002-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 8199
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/653/06653425.pdf
[firstpage_image] =>[orig_patent_app_number] => 10306280
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/306280 | High refractive index and high photosensitive optical materials and method for preparing the same | Nov 26, 2002 | Issued |
Array
(
[id] => 993730
[patent_doc_number] => 06916829
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-07-12
[patent_title] => 'Method for enhancing mutant enzyme activity in gaucher disease'
[patent_app_type] => utility
[patent_app_number] => 10/304395
[patent_app_country] => US
[patent_app_date] => 2002-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 29
[patent_no_of_words] => 11860
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/916/06916829.pdf
[firstpage_image] =>[orig_patent_app_number] => 10304395
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/304395 | Method for enhancing mutant enzyme activity in gaucher disease | Nov 25, 2002 | Issued |
| 10/168940 | Compositions and methods for l-nucleosides, l-nucleotides, and their analogs | Nov 25, 2002 | Abandoned |
Array
(
[id] => 7463906
[patent_doc_number] => 20040101547
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-27
[patent_title] => 'Wound dressing containing aldehyde-modified regenerated polysaccharide'
[patent_app_type] => new
[patent_app_number] => 10/304781
[patent_app_country] => US
[patent_app_date] => 2002-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4174
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20040101547.pdf
[firstpage_image] =>[orig_patent_app_number] => 10304781
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/304781 | Wound dressing containing aldehyde-modified regenerated polysaccharide | Nov 25, 2002 | Abandoned |
Array
(
[id] => 761390
[patent_doc_number] => 07012139
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-03-14
[patent_title] => 'Process of preparing delayed-dissolution cellulose ethers'
[patent_app_type] => utility
[patent_app_number] => 10/303282
[patent_app_country] => US
[patent_app_date] => 2002-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3793
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/012/07012139.pdf
[firstpage_image] =>[orig_patent_app_number] => 10303282
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/303282 | Process of preparing delayed-dissolution cellulose ethers | Nov 24, 2002 | Issued |
Array
(
[id] => 7136482
[patent_doc_number] => 20040044067
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-04
[patent_title] => 'Toralactone and its derivation and the use of decreasing blood-fat and losing weight'
[patent_app_type] => new
[patent_app_number] => 10/203876
[patent_app_country] => US
[patent_app_date] => 2002-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2257
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20040044067.pdf
[firstpage_image] =>[orig_patent_app_number] => 10203876
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/203876 | Toralactone and its derivation and the use of decreasing blood-fat and losing weight | Nov 21, 2002 | Abandoned |
Array
(
[id] => 6843914
[patent_doc_number] => 20030149261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Sir2 products and activities'
[patent_app_type] => new
[patent_app_number] => 10/301514
[patent_app_country] => US
[patent_app_date] => 2002-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 13324
[patent_no_of_claims] => 119
[patent_no_of_ind_claims] => 37
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20030149261.pdf
[firstpage_image] =>[orig_patent_app_number] => 10301514
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/301514 | Sir2 products and activities | Nov 20, 2002 | Issued |
Array
(
[id] => 7470741
[patent_doc_number] => 20040102617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-27
[patent_title] => 'Specific acylation of carbohydrate hydroxyls'
[patent_app_type] => new
[patent_app_number] => 10/302263
[patent_app_country] => US
[patent_app_date] => 2002-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1440
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20040102617.pdf
[firstpage_image] =>[orig_patent_app_number] => 10302263
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/302263 | Specific acylation of carbohydrate hydroxyls | Nov 20, 2002 | Abandoned |
Array
(
[id] => 7474329
[patent_doc_number] => 20040097466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => 'Treatment of a patient suffering from cell surface thrombosis disorders using enhanced absorption of arginine'
[patent_app_type] => new
[patent_app_number] => 10/299506
[patent_app_country] => US
[patent_app_date] => 2002-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4858
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20040097466.pdf
[firstpage_image] =>[orig_patent_app_number] => 10299506
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/299506 | Treatment of a patient suffering from cell surface thrombosis disorders using enhanced absorption of arginine | Nov 18, 2002 | Abandoned |
Array
(
[id] => 6818213
[patent_doc_number] => 20030069171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-10
[patent_title] => 'Nutritional composition for the treatment of connective tissue'
[patent_app_type] => new
[patent_app_number] => 10/287590
[patent_app_country] => US
[patent_app_date] => 2002-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1980
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20030069171.pdf
[firstpage_image] =>[orig_patent_app_number] => 10287590
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/287590 | Nutritional composition for the treatment of connective tissue | Nov 4, 2002 | Issued |
Array
(
[id] => 6668384
[patent_doc_number] => 20030113367
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-19
[patent_title] => 'Alprazolam inclusion complexes and pharmaceutical compositions thereof'
[patent_app_type] => new
[patent_app_number] => 10/220563
[patent_app_country] => US
[patent_app_date] => 2002-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3669
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20030113367.pdf
[firstpage_image] =>[orig_patent_app_number] => 10220563
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/220563 | Alprazolam inclusion complexes and pharmaceutical compositions thereof | Oct 29, 2002 | Abandoned |
Array
(
[id] => 6683895
[patent_doc_number] => 20030119759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Recovery of isoflavones from soy molasses'
[patent_app_type] => new
[patent_app_number] => 10/283671
[patent_app_country] => US
[patent_app_date] => 2002-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8689
[patent_no_of_claims] => 82
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119759.pdf
[firstpage_image] =>[orig_patent_app_number] => 10283671
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/283671 | Recovery of isoflavones from soy molasses | Oct 29, 2002 | Abandoned |
Array
(
[id] => 7385984
[patent_doc_number] => 20040082541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-29
[patent_title] => 'Inclusion complex of Rifampicin, an anti-tubercular drug, with beta-cyclodextrin or 2-hydroxypropyl beta-cyclodextrin and a process thereof'
[patent_app_type] => new
[patent_app_number] => 10/281533
[patent_app_country] => US
[patent_app_date] => 2002-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2168
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20040082541.pdf
[firstpage_image] =>[orig_patent_app_number] => 10281533
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/281533 | Inclusion complex of Rifampicin, an anti-tubercular drug, with β-cyclodextrin or 2-hydroxypropyl β-cyclodextrin and a process thereof | Oct 27, 2002 | Issued |
Array
(
[id] => 432327
[patent_doc_number] => 07265100
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-09-04
[patent_title] => 'Separation of regioisomers of metal phthalocyanines'
[patent_app_type] => utility
[patent_app_number] => 10/493971
[patent_app_country] => US
[patent_app_date] => 2002-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5661
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/265/07265100.pdf
[firstpage_image] =>[orig_patent_app_number] => 10493971
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/493971 | Separation of regioisomers of metal phthalocyanines | Oct 27, 2002 | Issued |